Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (521-530 of 565) with videos related to

Pageof 57
Sort By:
JACC. Heart Failure|December 3, 2014
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trialW H Wilson Tang, Matthias Dupont, Adrian F Hernandez, et al.
Heart Rhythm|May 17, 2014
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trialBenjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation|June 27, 2007
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?Jennifer S Li, Eric Yow, Katherine Y Berezny, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR studyLan Shen, Bimal R Shah, Eric M Reyes, et al.
European Heart Journal|August 24, 2014
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trialGünter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
JAMA|July 9, 2004
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trialMichael A Blazing, James A de Lemos, Harvey D White, et al.
American Heart Journal|September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
Plos One|August 12, 2021
A holistic approach for suppression of COVID-19 spread in workplaces and universitiesSarah F Poole, Jessica Gronsbell, Dale Winter, et al.
The American Journal of Cardiology|March 5, 2004
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study)David E Kandzari, Alan Chu, Bruce R Brodie, et al.
European Heart Journal|November 4, 2004
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registryEric J Velazquez, Gary S Francis, Paul W Armstrong, et al.
Pageof 57

Showing results (521-530 of 565) with videos related to

Sort By:
Pageof 57
JACC. Heart Failure|December 3, 2014
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trialW H Wilson Tang, Matthias Dupont, Adrian F Hernandez, et al.
Heart Rhythm|May 17, 2014
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trialBenjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation|June 27, 2007
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?Jennifer S Li, Eric Yow, Katherine Y Berezny, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR studyLan Shen, Bimal R Shah, Eric M Reyes, et al.
European Heart Journal|August 24, 2014
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trialGünter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
JAMA|July 9, 2004
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trialMichael A Blazing, James A de Lemos, Harvey D White, et al.
American Heart Journal|September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
Plos One|August 12, 2021
A holistic approach for suppression of COVID-19 spread in workplaces and universitiesSarah F Poole, Jessica Gronsbell, Dale Winter, et al.
The American Journal of Cardiology|March 5, 2004
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study)David E Kandzari, Alan Chu, Bruce R Brodie, et al.
European Heart Journal|November 4, 2004
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registryEric J Velazquez, Gary S Francis, Paul W Armstrong, et al.
Pageof 57